Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keurig Dr Pepper’s SEC filings tell the story behind both its countertop brewers and its famous sodas—yet those documents can easily top 300 pages. If you have ever searched for “Keurig Dr Pepper SEC filings explained simply� or wondered which segment drives pod revenue, you are in the right place.
Our AI-powered workspace breaks down every filing type the moment it hits EDGAR. Open a 10-K and you will see coffee pod volume, concentrate margins and hedging disclosures highlighted in plain English. Need the latest “Keurig Dr Pepper quarterly earnings report 10-Q filing�? We extract brewer placement numbers and year-over-year price/mix so you can compare quarters fast. Material events move quickly, so each “Keurig Dr Pepper 8-K material events explained� note arrives with context, links to prior guidance, and peer benchmarks.
Insider activity is equally transparent: track “Keurig Dr Pepper Form 4 insider transactions real-time� to see when executives convert options or when large holders adjust stakes. Our alerts flag unusual patterns and summarize footnotes, answering the popular query “Keurig Dr Pepper executive stock transactions Form 4�. Proxy season? One click delivers “Keurig Dr Pepper proxy statement executive compensation� insights, spotlighting equity grants tied to brewer penetration. Whether you are modelling pod growth, checking dividend safety, or scanning “Keurig Dr Pepper annual report 10-K simplified�, Stock Titan’s AI turns dense disclosures into actionable paragraphs—saving hours and ensuring nothing is missed.
Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.� On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.
- Nature of transaction: “A� code denotes acquisition from equity award; “F� code denotes shares withheld for taxes—neither represents an open-market trade.
- Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
- Alignment impact: The executive retains a sizable equity stake (�3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.
Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.
Keurig Dr Pepper (KDP) Chief Human Resources Officer Mary Beth DeNooyer has sold 12,000 shares of common stock at a weighted average price of $33.64 per share on June 20, 2025. The transaction was executed through a pre-established Rule 10b5-1 trading plan adopted on November 1, 2024.
The sale prices ranged from $33.32 to $33.86 per share. Following the transaction, DeNooyer continues to hold 106,511 shares directly. The Rule 10b5-1 trading plan provides an affirmative defense against insider trading allegations by establishing predetermined trading parameters.
- Transaction value: Approximately $403,680
- Trading plan established: November 1, 2024
- Form 4 filed: June 24, 2025
- Ownership: Direct holding
Keurig Dr Pepper Inc. (Nasdaq: KDP) used a Regulation FD presentation on 23�24 June 2025 to reaffirm its previously issued full-year 2025 outlook. Management reiterated two key non-GAAP targets:
- Constant-currency net sales: expected to rise in the mid-single-digit percentage range versus 2024.
- Adjusted diluted EPS: projected to expand in the high-single-digit percentage range.
No changes were made to the guidance originally communicated earlier in the year, signalling that current trading conditions and cost assumptions remain intact despite ongoing macroeconomic uncertainties. The filing contains standard cautionary language about forward-looking statements and highlights that reconciliations to GAAP metrics are not provided because mark-to-market and other uncontrollable items cannot be reasonably estimated.
The 8-K is furnished under Item 7.01 and therefore is not deemed "filed" for liability purposes under Section 18 of the Exchange Act. No other operational updates, financial tables, acquisitions, or management changes were disclosed.
Keurig Dr Pepper held its Annual Meeting of Stockholders on June 18, 2025, where shareholders voted on three key proposals:
1. Board Elections: All nine director nominees were successfully elected with strong majority support. Notable directors include Timothy Cofer (1.22B votes for), Robert Gamgort (1.21B votes for), and Pamela Patsley (1.17B votes for).
2. Say-on-Pay Vote: Shareholders approved the advisory resolution on executive compensation with 1.15 billion votes in favor (94.5% approval) versus 67.1 million against.
3. Auditor Ratification: Deloitte & Touche LLP was confirmed as the independent auditor for FY2025, receiving overwhelming support with 1.24 billion votes in favor (99.7% approval).
The high approval rates across all proposals indicate strong shareholder confidence in KDP's governance and management. The meeting had significant participation with over 1.2 billion shares voted.
Form 144 Notice filed for Keurig Dr Pepper (KDP) indicates insider Mary Beth Denooyer's proposed sale of 36,000 shares of common stock with an aggregate market value of $1,195,560 through J.P. Morgan Securities. The sale is scheduled for June 20, 2025, on NASDAQ.
The securities to be sold were acquired through multiple transactions:
- Two RSU vestings in March 2024 totaling 12,746 shares
- Five open market purchases between August-December 2019 totaling 23,254 shares
Recent trading history shows Denooyer has sold 60,000 shares in the past 3 months through five separate transactions between April-June 2025, generating approximately $2.05 million in gross proceeds. The average selling price across these transactions was around $34.21 per share.
FAQ
What is the current stock price of Keurig Dr Pepper (KDP)?
What is the market cap of Keurig Dr Pepper (KDP)?
What core segments does Keurig Dr Pepper operate in?
How does KDP manage product distribution?
What distinguishes KDP's beverage offerings?
Which markets does KDP primarily serve?
How does KDP maintain its competitive advantage?
What keywords highlight KDP’s industry expertise?
How does KDP address consumer needs?
What role does innovation play in KDP’s strategy?
